Does your company need D & O Insurance?
Recently, a small business owner decided it was time to put a board of directors in place for his company. After several years of growth, the owner felt a board could help focus the company’s direction. Upon learning this, several people mentioned that it was prudent to get directors and officers liability insurance.
Directors, officers, and organizations are held accountable to investors and shareholders for the financial management of the company they work for. They take strategic risks for the growth of the business. Sometimes the choices they make can impact the business negatively, which can put them at risk of being sued. This insurance can be key to your business’s risk management plan.
If you are running a public company Directors and Officers Insurance could be the deciding factor in bringing on a qualified Director.
D & O Insurance demonstrates your professionalism and ensures you’ll have protection and world class representation if you and your fellow directors are ever sued.
Get a Free Quote from a Commercial Insurance Representative in Minutes!
Don’t feel like filling in a form?
Skip ahead of the line and call toll-free: 405-829-6978
Weekly Update: August 23rd, 2022
As it was summed up in a headline- “There’s no simple story to tell about the current market”.
There are a million factors and everyday things change as influencers like Elon Musk move the chess pieces around. Treasuries up one day, Nasdaq down, the dollar up against the Euro. What does it all mean.
To me this kind of very erratic market conditions and crazy volatility signal a great time to keep your powder dry and if anything look at high yield ETF’s until there is some clear direction again and my bet is that might be some time and maybe until the next federal election.
·Senior Markets Editor
Tue, August 23, 2022 at 5:30 AM
There’s a ton going on in markets right now.
Stocks got smoked to start the week, with the summer rally appearing to have stalled.
The tech-heavy Nasdaq is now down a quick 5% in just a few trading days after rallying about 25% from mid-June to mid-August.
On Monday, the S&P 500 endured its worst day since June 16, a date that probably sounds familiar to market enthusiasts — it’s the same day the S&P 500 hit its most recent bottom.
Treasury yields are rising as investors ratchet up bets the Fed won’t change course imminently. Still, the yield curve remains deeply inverted, a situation that has typically preceded recession.
The dollar is back near 20-year highs against the euro as the euro once again traded below parity with the dollar on Monday as concerns grow about the economic outlook in Europe.
The 21st Century Investment Bank Capital Raises + Strategic Advisory
Donald Capital is a boutique Investment Bank that focuses on raising capital for emerging growth companies in the U.S. and around the globe.
Ideally, we like to work with Private and Public companies with a good management team, a compelling business plan, and the ability to gain market share.
For more information go to: www.DonaldCapital-NY.com
The Premier Operating System for Publicly Traded Companies
Track your investors’ buying and selling behaviors and use those insights to engage them across marketing channels.
Know who’s buying and selling and monitor trading in real time. Unlock your shareholders contact info and build full contact profiles on your shareholders, including emails, phone numbers, and social media accounts to engage them and target new investors through media campaigns.
To schedule a demo email me at email@example.com or call 727-459-7378
8-15-2022 SRAX (NASDAQ: SRAX)
SRAX Secures Revolving Credit Facility and Launches Stock Portfolio Tracker
LOS ANGELES, Aug. 15, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the company has entered into a revolving credit facility and launched a website that allows investors to track the current value of the company’s marketable securities portfolio.
The revolving credit facility allows the company to draw up to $9.5M over the next 2 years. The borrowing base of the Credit Facility is determined by the company’s cash and up to 70% of the market value of the marketable securities held by the company, not to exceed $9.5M. The repayment of the Credit Facility is based on a percentage of the sales of the marketable securities from Sequire customers. The amount of the Credit Facility which is outstanding is convertible into common shares at $15 per share. It also requires the company to repurchase a minimum of $1M worth of SRAX’s stock under $5 per share.
8-15-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF Toronto: ATE.TO)
Antibe Therapeutics Reports Q1 2023 Interim Financial and Operating Results
– Phase II acute pain program to initiate in September
– Ended quarter with $50 million in cash and equivalents, providing over two years of runway
TORONTO, August 15, 2022–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, has filed its financial and operating results for the fiscal quarter ended June 30, 2022.
“We are really pleased with our progress,” commented Dan Legault, Antibe’s CEO. “The data we’ve collected supports otenaproxesul’s target profile as a GI-safe, non-opioid oral analgesic for acute pain – a multi-billion dollar market devoid of innovation and in great need of novel therapies. We’re particularly excited to launch the Phase II molar extraction study next month, enabling us to collect data in post-operative patients for the first time. The results of this study should allow us to identify the optimal dosing regimens for the larger Phase II bunionectomy trial next year.”
7-25-2022 International Food and Beverage (OTC IFBC)
IFBC Joins SRAX Platform
PLAINVIEW, NY / ACCESSWIRE / July 25, 2022 /Italian Food & Beverage Corp. (OTC Pink:IFBC) Is pleased to announce that it has joined the SRAX Premier Operating System for Publicly Traded Companies. The benefits to IFBC from this arrangement extend from the fostering of the IFBC brand to potential investors, to creating an awareness of IFBC and its products to beverage distribution companies and other marketing channels across the entire USA. SRAXInc. is a NASDAQ company, which, by way of its sophisticated financial technology, unlocks valuable data and insightful nuances of the shareholder bases for publicly traded companies. With its premier investor intelligence and communications platform, Sequire, through which companies can carefully track their investors’ behaviors, trends, and patterns, and use those insights to engage current and potential investors across a host of marketing channels.
07-26-2022 CanB Corp (OTC CANB)
Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.
Initial 3-Year Worldwide Agreement
HICKSVILLE, NY, July 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and other wellness products and programs, is pleased to announce the signing of a Manufacturing and Distribution Agreement with Forever Brands to produce a line of nutritional Superfoods drink mix for Brooke Burke and her company, BB Body, Inc.
The initial 3-year worldwide agreement covers the sale, manufacturing and distribution of the Superfood and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct to consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, all-natural metabolic energy drink and other products that may be mutually agreed from time to time.
7-8-2022 Antibe Therapeutics, Inc. (OTCQX: ATBPF Toronto: ATE.TO)
Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…
Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22
Antibe Therapeutics, Inc. (OTC:ATBPF) (TSX:ATE.TO) is developing otenaproxesul as a solution to the dose-related gastrointestinal (GI) side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs). It uses naproxen as a base molecule with a hydrogen sulfide moiety covalently attached. Hydrogen sulfide (H2S) is an important gasotransmitter, which is a gas that serves as an important signaling molecule in the body.
The company is developing otenaproxesul for the management of acute pain, with an initial indication of post-operative pain. The most recent pharmacokinetic/pharmacodynamic (PK/PD) study conducted by Antibe examined various loading doses of otenaproxesul. The results from this study suggests that the drug has a potentially rapid onset of action that would be necessary for an acute pain treatment.
6-6-2022 SRAX (NASDAQ: SRAX)
SRAX Reports Record Full Year and Q4 2021 Financial Results
LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is providing full year financial results.
SRAX exceeded guidance of $31.5M for 2021, with SRAX totaling $28.6 million in revenue, and its former subsidiary, BIGtoken, totaling $3.4 million in revenue. Due to the deconsolidation of BIGtoken as of December 31, 2021, the following full year earnings report includes BIGtoken’s results from operations as discontinued operations. Due to an increase in bookings, SRAX is providing guidance of $47M-$50M for 2022.
5-31- 2022 Ecrid, Inc (OTC ECDD)
ECRID/ResMac Mortgage Strikes Deal That Can Change the Entire Credit Industry
PALM BEACH, FL , May 31, 2022 /PRNewswire/ — ECRID, Inc. (Stock Symbol: ECDD) and ResMac Mortgage have teamed up to help millions of Americans become home owners who have difficulty obtaining mortgages or refinancing existing mortgages in this current economic climate. ECRID, the new Credit Bureau offers the tools and resources to assist Americans in taking control of their financial destinies to become financially stable and build wealth. Through the ECRID platform www.ecrid.com customers can sign up and create their own ECRID Credit Report and Apply for a Mortgage through ECRID Lending Corp. and begin their journey to financial health.
5-17-2022 Coeptis Therapeutics, Inc. OTC COEP
Coeptis Therapeutics Enters into Exclusive Option Agreement with University of Pittsburgh for Rights to CAR-T Technologies Designed to Target Multiple Cancer Indications, Including Hematologic and Solid Tumors
WEXFORD, Pa., May 17, 2022 /PRNewswire/ — Coeptis Therapeutics, Inc. (OTC PINK: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced entry into an exclusive option agreement with the University of Pittsburgh for the rights to three chimeric antigen receptor T cell (CAR-T) technologies that offer the potential to address a range of hematologic and solid tumors. Among the initial cancer indications under development are pre-clinical programs targeting breast cancer and ovarian cancer. Terms of the deal were not disclosed.
The exclusive option agreement involves the intellectual property rights to three technologies jointly developed in the laboratories of Jason Lohmueller, Ph.D., Assistant Professor of Immunology; Alexander Deiters, Ph.D., Professor of Chemistry; and Olivera Finn, Ph.D., Professor of Immunology: 1) mSA2 affinity-enhanced biotin-binding CAR, 2) universal self-labeling SynNotch and CARs for programable antigen-targeting, and 3) conditional control of universal CAR-T cells through stimulus-reactive adaptors. Per the option agreement, Coeptis paid the University of Pittsburgh a non-refundable fee for the exclusive option to license the patent rights to each of the three technologies. Coeptis has until October 29, 2022, to exercise the options and pay the specified exercise considerations. The option agreement may be extended an additional six months, subject to the agreement of both parties.
Check out our latest commercial properties including an Amazing Private Island or Resort Development Property in Panama
Message me on Linkedin and check our latest commercial listings:
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
|August 23, 2022 |
COMPANY QUOTES, LISTINGS RESEARCH AND NEWS
Coeptis Therapeutics, Inc. Ecrid, Inc (ECDD) Profile
Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News
Can B Corp (CANB) Profile News
Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News
Social Reality, Inc. (SRAX) Profile News
International Food and Beverage Profile
August 22nd, 2022
ValuEngine Weekly Report
August 22, 2022 by Herb Blank
Do Not Be Alarmed By the Closing of JP Morgan Indexed ETFs. I say this even as I say that I believe this may be part of an emerging trend. Many mutual fund companies that are known for touting active management but stuck their feet in the water with ETFs will likely follow suit.
The press release said that J.P. Morgan Asset Management will liquidate two exchange-traded funds:
ValuEngine Capital Management LLC (VECM) is pleased to announce the addition of Jordan Kimmel to the team as the new Chief Equity Strategist and portfolio manager. VECM is a Registered Investment Advisor (RIA) that invests based on the proprietary, quantitative research produced by ValuEngine Inc. It is an important partnership between two companies: ValuEngine conducts research, and ValuEngine Capital Management LLC actively trades client funds using this research.
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Black Swan Research Coverage and Subscription Service
Event Calendar Updates
NIBA is back
September 7-8, 2022
At the luxurious Margaritaville Hollywood Beach Resort in Hollywood, Florida
|NIBA’s upcoming Florida Conference is a one-and-a-half day fast-paced, intimate event that provides private and public issuers, regardless of size or industry, a unique platform to present their individuals stories to prospective investors, financing partners, market makers and market professionals, all experienced within the capital markets.|
The 2022 LD Micro Invitational, Hosted by SRAX, Featured Many Influential Companies – Replays Available
LOS ANGELES, June 16, 2022 (GLOBE NEWSWIRE) — SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, hosted the 2022 LD Micro Invitational, both in-person in Westlake Village, CA and virtually via their Sequire Virtual Events platform, on June 7th-9th. The conference featured 187 companies, presenting for 25 minutes each. Replays are now available for viewing.
Rocky Mountain Microcap Conference IX.
The conference was a good success with great attendance and a recap will be available soon.
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
SMM Global Twitter Acct (Impressions last 30 days) 520
Direct Email * 220,000